John Rieth
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Intralesional Injection of Talimogene Laherparepvec (NCT06660810) | John Rieth | 2025-03-03 |
| Palbociclib and Pembrolizumab in Sarcoma (NCT06113809) | John Rieth | 2024-02-01 |
| TVEC and Preop Radiation for Sarcoma (8 ml Dose) (NCT04599062) | John Rieth | 2020-09-10 |
Track John Rieth automatically
Every clearance here is in the API, with alerts when new ones post.